Surface Engineering of HEK293 Cell-Derived Extracellular Vesicles for Improved Pharmacokinetic Profile and Targeted Delivery of IL-12 for the Treatment of Hepatocellular Carcinoma

References

• Sterzenbach U, Putz U, Low LH, Silke J, Tan SS, Howitt J. Engineered exosomes as vehicles for biologically active proteins. Mol Ther. 2017;25(6):1269–1278. doi:10.1016/j.ymthe.2017.03.030
   PubMed Web of Science ®Google Scholar
• O’Brien K, Breyne K, Ughetto S, Laurent LC, Breakefield XO. RNA delivery by extracellular vesicles in mammalian cells and its applications. Nat Rev Mol Cell Biol. 2020;21(10):585–606. doi:10.1038/s41580-020-0251-y
   PubMed Web of Science ®Google Scholar
• Giassafaki LN, Siqueira S, Panteris E, et al. Towards analyzing the potential of exosomes to deliver microRNA therapeutics. J Cell Physiol. 2021;236(2):1529–1544. doi:10.1002/jcp.29991
   PubMed Web of Science ®Google Scholar
• Cheng L, Hill AF. Therapeutically harnessing extracellular vesicles. Nat Rev Drug Discov. 2022;21(5):379–399. doi:10.1038/s41573-022-00410-w
   PubMed Web of Science ®Google Scholar
• Fang Z, Zhang X, Huang H, Jun W. Exosome based miRNA delivery strategy for disease treatment. Chin Chem Lett. 2022;33(4):1693–1704. doi:10.1016/j.cclet.2021.11.050
   Web of Science ®Google Scholar
• Cross R. Meet the exosome, the rising star in drug delivery. Available from: https://cen.acs.org/business/start-ups/Meet-exosome-rising-star-drug/96/i31. Accessed January 4, 2023.
   Google Scholar
• Kalra H, Drummen GP, Mathivanan S. Focus on extracellular vesicles: introducing the next small big thing. Int J Mol Sci. 2016;17(2):170. doi:10.3390/ijms17020170
   PubMed Web of Science ®Google Scholar
• Zhu X, Badawi M, Pomeroy S, et al. Comprehensive toxicity and immunogenicity studies reveal minimal effects in mice following sustained dosing of extracellular vesicles derived from HEK293T cells. J Extracell Vesicles. 2017;6(1):1324730. doi:10.1080/20013078.2017.1324730
   PubMed Web of Science ®Google Scholar
• Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367(6478). doi:10.1126/science.aau6977
   PubMed Web of Science ®Google Scholar
• Cully M. Exosome-based candidates move into the clinic. Nat Rev Drug Discov. 2021;20(1):6–7. doi:10.1038/d41573-020-00220-y
   PubMed Web of Science ®Google Scholar
• Mulcahy LA, Pink RC, Carter DR. Routes and mechanisms of extracellular vesicle uptake. J Extracell Vesicles. 2014;3(1):24641.
   PubMedGoogle Scholar
• Gupta D, Liang X, Pavlova S, et al. Quantification of extracellular vesicles in vitro and in vivo using sensitive bioluminescence imaging. J Extracell Vesicles. 2020;9(1):1800222. doi:10.1080/20013078.2020.1800222
   PubMed Web of Science ®Google Scholar
• Kang M, Jordan V, Blenkiron C, Chamley LW. Biodistribution of extracellular vesicles following administration into animals: a systematic review. J Extracell Vesicles. 2021;10(8):e12085. doi:10.1002/jev2.12085
   PubMed Web of Science ®Google Scholar
• Charoenviriyakul C, Takahashi Y, Morishita M, Nishikawa M, Takakura Y. Role of extracellular vesicle surface proteins in the pharmacokinetics of extracellular vesicles. Mol Pharm. 2018;15(3):1073–1080. doi:10.1021/acs.molpharmaceut.7b00950
   PubMedGoogle Scholar
• Williams C, Royo F, Aizpurua-Olaizola O, et al. Glycosylation of extracellular vesicles: current knowledge, tools and clinical perspectives. J Extracell Vesicles. 2018;7(1):1442985. doi:10.1080/20013078.2018.1442985
   PubMed Web of Science ®Google Scholar
• Hoshino A, Costa-Silva B, Shen TL, et al. Tumour exosome integrins determine organotropic metastasis. Nature. 2015;527(7578):329–335. doi:10.1038/nature15756
   PubMed Web of Science ®Google Scholar
• Altei WF, Pachane BC, Dos Santos PK, et al. Inhibition of alphavbeta3 integrin impairs adhesion and uptake of tumor-derived small extracellular vesicles. Cell Commun Signal. 2020;18(1):158. doi:10.1186/s12964-020-00630-w
   PubMed Web of Science ®Google Scholar
• Grigoryeva ES, Savelieva OE, Popova NO, Cherdyntseva NV, Perelmuter VM. Do tumor exosome integrins alone determine organotropic metastasis? Mol Biol Rep. 2020;47(10):8145–8157. doi:10.1007/s11033-020-05826-4
   PubMed Web of Science ®Google Scholar
• Casari I, Howard JA, Robless EE, Falasca M. Exosomal integrins and their influence on pancreatic cancer progression and metastasis. Cancer Lett. 2021;507:124–134. doi:10.1016/j.canlet.2021.03.010
   PubMed Web of Science ®Google Scholar
• Shimoda A, Miura R, Tateno H, et al. Assessment of surface glycan diversity on extracellular vesicles by lectin microarray and glycoengineering strategies for drug delivery applications. Small Methods. 2022;6(2):e2100785. doi:10.1002/smtd.202100785
   PubMed Web of Science ®Google Scholar
• Williams C, Pazos R, Royo F, et al. Assessing the role of surface glycans of extracellular vesicles on cellular uptake. Sci Rep. 2019;9(1):11920. doi:10.1038/s41598-019-48499-1
   PubMedGoogle Scholar
• Nishida-Aoki N, Tominaga N, Kosaka N, Ochiya T. Altered biodistribution of deglycosylated extracellular vesicles through enhanced cellular uptake. J Extracell Vesicles. 2020;9(1):1713527. doi:10.1080/20013078.2020.1713527
   PubMedGoogle Scholar
• Feng M, Gao W, Wang R, et al. Therapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinoma. Proc Natl Acad Sci U S A. 2013;110(12):E1083–1091. doi:10.1073/pnas.1217868110
   PubMed Web of Science ®Google Scholar
• Hurwitz SN, Meckes DG Jr. An adaptable polyethylene glycol-based workflow for proteomic analysis of extracellular vesicles. Methods Mol Biol. 2017;1660:303–317.
   PubMedGoogle Scholar
• Song Z, Xu Y, Zhang L, et al. Comprehensive proteomic profiling of urinary exosomes and identification of potential non-invasive early biomarkers of alzheimer’s disease in 5XFAD mouse model. Front Genet. 2020;11:565479. doi:10.3389/fgene.2020.565479
   PubMed Web of Science ®Google Scholar
• Ferries S, Perkins S, Brownridge PJ, et al. Evaluation of parameters for confident phosphorylation site localization using an orbitrap fusion tribrid mass spectrometer. J Proteome Res. 2017;16(9):3448–3459. doi:10.1021/acs.jproteome.7b00337
   PubMed Web of Science ®Google Scholar
• Ben Ami Pilo H, Khan KS, Lühle J, et al. Sialylated N-glycans mediate monocyte uptake of extracellular vesicles secreted from Plasmodium falciparum-infected red blood cells. J Extracell Bio. 2022;1(2):e33. doi:10.1002/jex2.33
   PubMedGoogle Scholar
• Christianson HC, Svensson KJ, van Kuppevelt TH, Li JP, Belting M. Cancer cell exosomes depend on cell-surface heparan sulfate proteoglycans for their internalization and functional activity. Proc Natl Acad Sci U S A. 2013;110(43):17380–17385. doi:10.1073/pnas.1304266110
   PubMed Web of Science ®Google Scholar
• Dusoswa SA, Horrevorts SK, Ambrosini M, et al. Glycan modification of glioblastoma-derived extracellular vesicles enhances receptor-mediated targeting of dendritic cells. J Extracell Vesicles. 2019;8(1):1648995. doi:10.1080/20013078.2019.1648995
   PubMed Web of Science ®Google Scholar
• Lazaro-Ibanez E, Faruqu FN, Saleh AF, et al. Selection of fluorescent, bioluminescent, and radioactive tracers to accurately reflect extracellular vesicle biodistribution in vivo. ACS Nano. 2021;15(2):3212–3227. doi:10.1021/acsnano.0c09873
   PubMed Web of Science ®Google Scholar
• Kamerkar S, LeBleu VS, Sugimoto H, et al. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature. 2017;546(7659):498–503. doi:10.1038/nature22341
   PubMed Web of Science ®Google Scholar
• Dooley K, McConnell RE, Xu K, et al. A versatile platform for generating engineered extracellular vesicles with defined therapeutic properties. Mol Ther. 2021;29(5):1729–1743. doi:10.1016/j.ymthe.2021.01.020
   PubMed Web of Science ®Google Scholar
• Staufer O, Hernandez Bucher JE, Fichtler J, Schroter M, Platzman I, Spatz JP. Vesicle induced receptor sequestration: mechanisms behind extracellular vesicle-based protein signaling. Adv Sci. 2022;9(13):e2200201. doi:10.1002/advs.202200201
   Web of Science ®Google Scholar
• Jung K, Ha JH, Kim JE, et al. Heterodimeric Fc-fused IL12 shows potent antitumor activity by generating memory CD8(+) T cells. Oncoimmunology. 2018;7(7):e1438800. doi:10.1080/2162402X.2018.1438800
   PubMed Web of Science ®Google Scholar
• Bernett M, Liu K, Bonzon C, et al. IL12 Fc-fusions engineered for reduced potency and extended half-life exhibit strong anti-tumor activity and improved therapeutic index compared to wild-type IL12 agents. J Immunother Cancer. 2021;9(Suppl 2):A736–A736. doi:10.1136/jitc-2021-SITC2021.707
   Google Scholar